Development of a novel patient-reported measure for acromegaly: the Acro-TSQ

PURPOSE: Somatostatin analogs (SSAs) represent a mainstay of medical treatment for acromegaly, currently available as either intramuscular or deep subcutaneous injections. Patient-reported outcomes (PROs) are increasingly common as relevant outcomes in studies of acromegaly and its treatment, but th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Fogelfeld, Leon, Gordon, Murray B., Sisco, Jill, Colwell, Hilary H., Ludlam, William H., Haviv, Asi, Mathias, Susan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842345/
https://www.ncbi.nlm.nih.gov/pubmed/31522359
http://dx.doi.org/10.1007/s11102-019-00986-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842345/
https://www.ncbi.nlm.nih.gov/pubmed/31522359
http://dx.doi.org/10.1007/s11102-019-00986-4

Ejemplares similares